Francisca Cuenca

PREVALENCIA DE DISLIPEMIA Y SU IMPACTO EN LOS CRITERIOS DIAGNÓSTICOS DE LA ENFERMEDAD DE WILSON: ANÁLISIS DEL REGISTRO DE LA AEEH

Marisa Ojeda, Luis García-Villareal, Zoe Mariñó, Marina Berenguer et autres

V-25 - FACTORES ASOCIADOS AL DESARROLLO DE COLANGITIS BILIAR PRIMARIA (CBP) EN PERSONAS CON ANTICUERPOS ANTI-MITOCONDRIALES (AMA): ESTUDIO MULTICÉNTRICO ESPAÑOL

Alvaro Diaz-González, Helena Hernández-évole, Lucía Jiménez, Manuel Luis Rodríguez Perálvarez et autres

MANEJO DE LAS PACIENTES CON COLANGITIS BILIAR PRIMARIA (CBP) EN LA ERA POSOBETICÓLICO (OCA): PRIMEROS DATOS DE EFECTIVIDAD EN VIDA REAL DE ELAFIBRANOR (ELA) Y SELADELPAR (SEL) DEL REGISTRO COLHAI

Alvaro Diaz-González, Cristina Montón, Marina Brosell, Agustin Castiella et autres

Genetic map of Wilson Disease in Spain: a great tool to improve diagnosis and screening

Pablo Alonso-Castellano, Zoe Mariñó, Antonio Tugores, Antonio Olveira et autres

BACKGROUND: a National Registry for Wilson disease (WD) was recently started by the Spanish Association for the Study of the Liver (AEEH). We evaluated the genetic data of the patients and the differences between regions and hospitals. METHODS: a multicentric observational study …

es, cl, us (code pays fourni par la source)

Reproductive and pregnancy control in Wilson disease patients in Spain

Marta Romero-Gutiérrez, Pablo Alonso, Marina Berenguer, Antonio Olveira et autres

BACKGROUND AND AIM: Recommendations on pregnancy, lactation, and contraception in women with Wilson disease are briefly stated in international guidelines but are not entirely homogeneous. Data regarding the management of these special events among patients with Wilson disease in Spain are lacking. …

es (code pays fourni par la source)

Outcomes and factors associated with relapse of vaccine-induced liver injury after SARS CoV-2 immunization: A nationwide study

Ana Barreira‐Díaz, Mar Riveiro‐Barciela, Eva Fernández Bonilla, Vanesa Bernal Monterde et autres

INTRODUCTION AND OBJECTIVES: Different patterns of liver injury have been reported in association with the SARS-CoV-2 vaccines. The aim of this study was to describe a nationwide cohort of patients with SARS CoV-2 vaccine-induced liver injury, focusing on treatment and the evolution …

es (code pays fourni par la source)

Human Immunodeficiency Virus/Hepatitis C Virus Coinfection in Spain: Prevalence and Patient Characteristics

Juan Berenguer, Antonio Rivero, Inmaculada Jarrín, M.J. Núñez et autres

Background. The purpose of this study was to assess the prevalence of anti-hepatitis C virus (HCV) antibodies (Abs) and active HCV infection in human immunodeficiency virus (HIV)-infected (HIV+) patients in Spain in 2015. This was a cross-sectional study. Methods. The study was …

es (code pays fourni par la source)

Prognostic Value of Transient Elastography in Human Immunodeficiency Virus-Infected Patients With Chronic Hepatitis C

Leire Perez Latorre, Antonio Rivero‐Juárez, Víctor Hontañón, Cristina Pérez Diez et autres

BACKGROUND: Our objective was to study the prognostic value of liver stiffness (LS) in HIV-infected patients with chronic hepatitis C (CHC). METHODS: We analyzed HIV-infected patients with compensated CHC and at least 1 determination of LS. The primary outcome was the occurrence …

es (code pays fourni par la source)

[Therapeutic update in hepatitis C].

María José Devesa, Francisca Cuenca, Sonia Montilla Izquierdo, Pilar Cubiles Sánchez-Pobre et autres

Hepatitis C virus infection is a major health burden affecting 130-170 million people worldwide. Approximately 10-30% of those with chronic hepatitis C will progress to cirrhosis over 20-30 years. The development of new direct-acting antivirals has changed the management of the disease, …

es (code pays fourni par la source)

Vitamin D deficiency and vitamin D therapy in chronic hepatitis C

José M. Ladero, María José Torrejón, Pilar Cubiles Sánchez-Pobre, Avelina Suárez et autres

BACKGROUND: Vitamin D has immunomodulatory properties, exerts an anti-hepatitis C virus (HCV) effect in vitro and improves response to interferon-based therapy in patients with chronic hepatitis C (CHC). Low serum levels of 25(OH) vitamin D [25(OH)D] are frequently found in CHC patients …

es (code pays fourni par la source)

Serum cystatin C: a non-invasive marker of liver fibrosis or of current liver fibrogenesis in chronic hepatitis C?

José M. Ladero, Maria Camila Cardenas, Luis M Ortega, Andrea González-Pino et autres

BACKGROUND: Serum levels of cystatin C, an endogenous inhibitor of cysteine proteases, provide an alternative method to creatinine-based criteria for measuring glomerular filtration rate. Preliminary data suggested that serum cystatin C levels parallel with the stage of liver fibrosis in chronic liver …

es (code pays fourni par la source)

Relation of IL28B Gene Polymorphism with Biochemical and Histological Features in Hepatitis C Virus-Induced Liver Disease

José A. G. Agúndez, Elena García‐Martín, Maria Luisa Maestro, Francisca Cuenca et autres

BACKGROUND/AIMS: Polymorphism at the IL28B gene may modify the course of hepatitis C virus (HCV) chronic infection. Our aim was to study the influence of IL28B rs12979860 gene polymorphism on the biochemistry and pathology of HCV-induced disease in the clinical course from …

es (code pays fourni par la source)